The Q2 approach for percutaneous peripheral neuromodulation stimulator implantation targeting the C2 dorsal root ganglion at the C2 lamina for treatment of intractable headache: a technical note
Pain Medicine · 2025
DOI: 10.1093/pm/pnae113 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pain Medicine, 2025. Verfasst von QiLiang Chen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University, Stanford, CA 94063, United States. Hauptthemen laut MEDLINE: Ganglia, Spinal, Transcutaneous Electric Nerve Stimulation, Headache Disorders, Electric Stimulation Therapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Gefördert von: BLRD VA, Stanford Medicine Endowed Directorship, VA Career Development.
Abstract (Originalsprache)
Objectives
Despite significant medical treatment advancements, interventional treatments for intractable headache disorders are limited. This study’s objective is to detail a novel percutaneous approach (the “Q2 approach”) and its technical considerations for implanting peripheral neuromodulation stimulators (PNS) to the C2 dorsal root ganglion (C2-DRG) at the C2 lamina, a previously unattempted target, as a treatment for intractable headache.
Methods
In an outpatient setting, under combined ultrasound and fluoroscopic guidance, PNS electrodes were percutaneously implanted at the C2-DRG in patients under moderate sedation. The final electrode position was determined by intraoperative patient feedback to ensure optimal stimulation. Four patients were included to demonstrate technical parameters and feasibility. Follow-ups were conducted on postoperative days 10, 30, 60, and 100–120.
Results
The Q2 approach allows safe C2-DRG PNS implantations in an outpatient setting. Average operative duration was <60 minutes. All 4 patients achieved >50% pain relief during the 60-day implant period, and 3 of 4 demonstrated sustained benefit beyond the implant period. No complications (eg, lead migration, infection) were observed.
Conclusions
The present technical note demonstrates the feasibility of a novel, safe, minimally invasive approach to access the C2-DRG at the C2 lamina for the treatment of intractable headaches. The use of PNS on the C2-DRG fills an important gap in headache management, as it provides an alternative neuromodulation treatment modality to the existing destruction/denervation-based techniques.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University, Stanford, CA 94063, United States.
- Anesthesiology Service, Veterans Affairs Palo Alto Health Care System, Palo Alto, CA 94304, United States.
ORCID-Profile: QiLiang Chen, Xiang Qian
Förderung
- BLRD VA
- Stanford Medicine Endowed Directorship
- VA Career Development
- Foundation for Anesthesia Education and Research Mentored Research Training
Zitieren
APA
Chen, Q., & Qian, X. (2025). The Q2 approach for percutaneous peripheral neuromodulation stimulator implantation targeting the C2 dorsal root ganglion at the C2 lamina for treatment of intractable headache: a technical note. Pain Medicine. https://doi.org/10.1093/pm/pnae113
Vancouver
Chen Q, Qian X. The Q2 approach for percutaneous peripheral neuromodulation stimulator implantation targeting the C2 dorsal root ganglion at the C2 lamina for treatment of intractable headache: a technical note. Pain Medicine. 2025. doi:10.1093/pm/pnae113
BibTeX
@article{Chen2025,
author = {Chen, QiLiang and Qian, Xiang},
title = {The Q2 approach for percutaneous peripheral neuromodulation stimulator implantation targeting the C2 dorsal root ganglion at the C2 lamina for treatment of intractable headache: a technical note},
journal = {Pain Medicine},
year = {2025},
doi = {10.1093/pm/pnae113}
}
EUVIMED